A retrospective single center study assessing the efficacy and safety and long-term follow-up of pediatric patients with relapsed/refractory Acute lymphoblastic leukemia receiving Blinatumomab
Latest Information Update: 10 Aug 2021
At a glance
- Drugs Blinatumomab (Primary)
- Indications Precursor B-cell lymphoblastic leukaemia-lymphoma
- Focus Expanded access; Therapeutic Use
- 10 Aug 2021 New trial record